These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6114740)

  • 1. Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?
    Jack DB
    Br J Clin Pharmacol; 1981 Apr; 11(4):402-6. PubMed ID: 6114740
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and biodistribution of a 125I-labeled beta-adrenoceptor antagonist bearing a cardioselectivity-enhancing N-substituent.
    Hanson RN; Blumberg JB; Poddubiuk ZM; Davis MA; Holman BL
    Int J Appl Radiat Isot; 1981 Jun; 32(6):429-33. PubMed ID: 6114044
    [No Abstract]   [Full Text] [Related]  

  • 3. On the antihypertensive mechanisms of beta-adrenoceptor antagonists in relation to intrinsic sympathomimetic activity, cardioselectivity and hydrophilicity.
    Man in't Veld AJ; Schalekamp MA
    J Pharmacol; 1983; 14 Suppl 2():69-104. PubMed ID: 6138473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of beta adrenoceptor antagonist affinity and cardioselectivity by radioligand-receptor assay.
    Gibson RE; Rzeszotarski WJ; Komai T; Reba RC; Eckelman WC
    J Pharmacol Exp Ther; 1979 Apr; 209(1):153-61. PubMed ID: 34714
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioiodinated derivatives of beta adrenoceptor blockers for myocardial imaging.
    Jiang VW; Gibson RE; Rzeszotarski WJ; Eckelman WC; Reba RC
    J Nucl Med; 1978 Aug; 19(8):918-24. PubMed ID: 28388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol.
    Conde S; Corral C; Lissavetzky ; Darias V; Martin D
    Farmaco Sci; 1986 Jan; 41(1):80-8. PubMed ID: 2869971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of beta-adrenoceptor antagonist cardioselectivity "in vivo": atenolol in anaesthetized cats.
    Kiyingi KS; Temple DM
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):59-72. PubMed ID: 6138005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomeric and polymeric beta-adrenergic antagonists.
    Pitha J; Kusiak JW
    Fed Proc; 1983 Feb; 42(2):279-83. PubMed ID: 6185366
    [No Abstract]   [Full Text] [Related]  

  • 9. Thin-layer chromatographic screening program for commonly used beta-blockers.
    Schütz H; Meister T
    Arzneimittelforschung; 1990 Jun; 40(6):651-3. PubMed ID: 1975740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcium and beta-adrenoceptor antagonists on beta-adrenoceptor density and Gs alpha expression in human atria.
    Jones CR; Fandeleur P; Harris B; Bühler FR
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):171S-173S. PubMed ID: 1980078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma beta-adrenoceptor blocker concentration and pharmacodynamic activity.
    Silke B
    Br J Clin Pharmacol; 1982 Feb; 13(2):256-7. PubMed ID: 6120714
    [No Abstract]   [Full Text] [Related]  

  • 13. The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors.
    Robberecht P; Delhaye M; Taton G; De Neef P; Waelbroeck M; De Smet JM; Leclerc JL; Chatelain P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):169-73. PubMed ID: 6136900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
    Pringle TH; McNeill AJ; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of beta-blockade.
    Smith U
    Cephalalgia; 1986; 6 Suppl 5():55-7. PubMed ID: 2879633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a radioreceptor assay for beta-adrenoceptor antagonists in plasma [proceedings].
    Barnett DB; Batta MI; Nahorski SR
    Br J Pharmacol; 1978 Nov; 64(3):449P. PubMed ID: 31225
    [No Abstract]   [Full Text] [Related]  

  • 17. The properties of beta-adrenoceptor antagonists.
    Shanks RG
    Postgrad Med J; 1976; 52 Suppl 4():14-20. PubMed ID: 9628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic blocking drugs.
    Gerber JG; Nies AS
    Annu Rev Med; 1985; 36():145-64. PubMed ID: 2581498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular orbital study of tissue selectivity in beta-adrenoceptor blocking agents.
    Germer HA
    J Pharm Pharmacol; 1974 Oct; 26(10):799-806. PubMed ID: 4156538
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.